The leader in transplantation department has 26~30 years of medical experience of Hematopoietic Stem Cell Transplantation. Has completed over more than 4000 cases of allogeneic hematopoietic stem cell transplantation and the transplantation efficacy, reaching international advanced level.

The team has extensive experience in the use of hematopoietic stem cell transplantation in the treatment of hematopoietic and immunodeficiency disorders, including Leukemia, myelodysplastic syndrome (MDS), MDS / MPN, lymphoma, multiple myeloma, aplastic anemia (acquired; congenital: Fanconi anemia, congenital keratosis), paroxysmal sleep Hemoglobinuria (PNH), hemophagocytic lymphohistiocytosis (familial and Epstein-Barr virus-related), X-linked non-IgA, idiopathic neutropenia, WAS, severe combined immunodeficiency disease, chronic granulomatous disease, high IgM syndrome, infantile inflammatory bowel disease, etc. In addition, the team also has abundant experience on transplantation indication, timing of grafting, the choices of transplantation options (identical-sibling, non-kid, kinship semi-coincidence, umbilical cord blood, identical gene, autologous transplantation), individualized preprocessing planning, prevention and treatment of transplant-related complications(GVHD, infection, relapse, etc.), salvage of refractory/relapsed leukemia, post-transplant immunotherapy and transplantation on child (minimum 2 months) and elderly (maximum 68 years old). For now, it has 19 100-level laminar wards and 2 transplantation inpatient areas